Search by Drug Name or NDC

NDC 64980-0377-10 Atomoxetine 60 mg/1 Details

Atomoxetine 60 mg/1

Atomoxetine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Rising Pharmaceuticals, Inc.. The primary component is ATOMOXETINE HYDROCHLORIDE.

MedlinePlus Drug Summary

Atomoxetine is used as part of a total treatment program to increase the ability to pay attention and decrease impulsiveness and hyperactivity in children and adults with ADHD. Atomoxetine is in a class of medications called selective norepinephrine reuptake inhibitors. It works by increasing the levels of norepinephrine, a natural substance in the brain that is needed to control behavior.

Related Packages: 64980-0377-10
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Atomoxetine

Product Information

NDC	64980-0377
Product ID	64980-377_fe7035f0-29cf-477c-80d1-e82adbd69b94
Associated GPIs	61354015100160
GCN Sequence Number	051493
GCN Sequence Number Description	atomoxetine HCl CAPSULE 60 MG ORAL
HIC3	H7Y
HIC3 Description	TX FOR ATTENTION DEFICIT-HYPERACT.(ADHD), NRI-TYPE
GCN	18781
HICL Sequence Number	024703
HICL Sequence Number Description	ATOMOXETINE HCL
Brand/Generic	Generic
Proprietary Name	Atomoxetine
Proprietary Name Suffix	n/a
Non-Proprietary Name	Atomoxetine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	60
Active Ingredient Units	mg/1
Substance Name	ATOMOXETINE HYDROCHLORIDE
Labeler Name	Rising Pharmaceuticals, Inc.
Pharmaceutical Class	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA079016
Listing Certified Through	2024-12-31

Package

NDC 64980-0377-10 (64980037710)

Pricing Information	N/A
NDC Package Code	64980-377-10
Billing NDC	64980037710
Package	1000 CAPSULE in 1 BOTTLE (64980-377-10)
Marketing Start Date	2017-05-30
NDC Exclude Flag	N